Ra Capital Management, L.P. Adicet Bio, Inc. Transaction History
Ra Capital Management, L.P.
- $6.64 Billion
- Q2 2024
A detailed history of Ra Capital Management, L.P. transactions in Adicet Bio, Inc. stock. As of the latest transaction made, Ra Capital Management, L.P. holds 7,541,000 shares of ACET stock, worth $11.2 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
7,541,000Holding current value
$11.2 Million% of portfolio
0.14%Shares
3 transactions
Others Institutions Holding ACET
# of Institutions
96Shares Held
66.3MCall Options Held
4.3KPut Options Held
36.3K-
Orbimed Advisors LLC San Diego, CA11.4MShares$17.1 Million0.33% of portfolio
-
Tang Capital Management LLC San Diego, CA8.22MShares$12.2 Million1.21% of portfolio
-
Goldman Sachs Group Inc New York, NY4.28MShares$6.38 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.62MShares$5.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.1MShares$4.62 Million0.0% of portfolio
About Adicet Bio, Inc.
- Ticker ACET
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,030,800
- Market Cap $59.6M
- Description
- Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...